Effects of β-hydroxybutyrate on cognition in memory-impaired adults

Neurobiology of Aging

Volumn 25, Issue 3, 2004, Pages 311-314

  Reger, Mark A ^a,b   Henderson, Samuel T ^c   Hale, Cathy ^d   Cholerton, Brenna ^a,b   Baker, Laura D ^a,b   Watson, G S ^a,b   Hyde, Karen ^a   Chapman, Darla ^a   Craft, Suzanne ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Accera Inc   (United States)

^d UNIVERSITY OF PUGET SOUND   (United States)

Author keywords

Alzheimer's disease; APOE; Cognition; Ketone bodies; Mild cognitive impairment; Neuropsychology; Hydroxybutyrate

Indexed keywords

3 HYDROXYBUTYRIC ACID; APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON 4; KETONE BODY; MEDIUM CHAIN TRIACYLGLYCEROL; PLACEBO; UNCLASSIFIED DRUG;

AGED; ANALYTIC METHOD; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRINKING; DRUG EFFECT; EMULSION; GENOTYPE; HUMAN; MEMORY DISORDER; MENTAL PERFORMANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECALL; TIME;

EID: 1242338801     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(03)00087-3     Document Type: Article

References (19)

1. Amiel S.A., Archibald H.R., Chunsey G., Williams A.K., Gale E.A.M. Ketone infusion lowers hormonal responses to hypoglycaemia: evidence for acute cerebral utilization of a non-glucose fuel. Clin. Sci. 81:1991;189-194.
2. Craft S., Zallen G., Baker L.D. Glucose and memory in mild senile dementia of the Alzheimer's type. J. Clin. Exp. Neuropsychol. 14:1992;253-267.
3. Craft S., Dagogo-Jack S., Wiethop B., Murphy C., Nevins R., Fleischman S.et al. The effects of hyperglycemia on memory and hormone levels in mild senile dementia of the Alzheimer's type: a longitudinal study. Behav. Neurosci. 107:1993;926-940.
4. Craft S., Asthana S., Schellenberg G., Baker L., Cherrier M., Boyt A.A. et al. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype. Ann. NY Acad. Sci. 903:2000;222-228.
5. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state. J. Psychiatr. Res. 12:1975;189-198.
6. Hertz L., Yu A.C.H., Kala G., Schousboe A. Neuronal-astrocytic and cytosolic-mitochondrial metabolite trafficking during brain activation, hyperammonemia and energy deprivation. Neurochem. Int. 37:2000;83-102.
7. Hoyer S. Oxidative energy metabolism in Alzheimer brains. Studies in early-onset and late onset cases. Mol. Chem. Neuropathol. 16:1992;207-224.
8. Izumi Y., Ishii K., Katsuki H., Benz A.M., Zorumski C.F. Beta-Hydroxybutyrate fuels synaptic function during development. Histological and physiological evidence in rat hippocampal slices. J. Clin. Invest. 101:1998;1121-1132.
9. Kashiwaya Y., Takeshima T., Mori N., Nakashima K., Clarke K., Veech R.L. D-β-Hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. PNAS. 97:2000;5440-5444.
10. Lezak MD. Neuropsychological assessment. New York: Oxford University Press; 1995.
11. Magistretti PJ. Brain energy metabolism. In: Zigmond MJ, Bloom FE, Landis SC, Roberts JL, Squire LR, editors. Fundamental neuroscience. San Diego: Academic Press; 1999. p. 389-413.
12. Manning C., Ragozzino M., Gold P.E. Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type. Neurobiol. Aging. 14:1993;523-528.
13. McCall A. The impact of diabetes on the CNS. Diabetes. 41:1992;557-570.
14. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
15. Meier-Ruge W., Bertoni-Freddari C., Iwangoff P. Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease. Gerontology. 40:1994;246-252.
16. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment. Arch. Neurol. 56:1999;303-308.
17. Rosen W.G., Mohs R.C., Davis K.L. A new rating scale for Alzheimer's disease. Am. J. Psychiatry. 141:1986;1356-1364.
18. Veneman T., Mitrakou A., Mokan M., Cryer P., Gerich J. Effect of hyperketonemia and hyperlacticacidemia on symptoms, cognitive dysfunction, and counterregulatory hormone responses during hypoglycemia in normal humans. Diabetes. 43:1994;1311-1317.
19. Williamson D.H., Mellanby J., Krebs H.A. Enzymatic determination of D(-)beta-hydroxybutyric acid and acetoacetic acid in blood. Biochem. J. 82:1962;90.